New Needle Design for Interferon Beta-1a Injections
Author Information
Author(s): Jaber Amer, Bozzato Gian B, Vedrine Lionel, Prais Wes A, Berube Julie, Laurent Philippe E
Primary Institution: Merck Serono International S.A.
Hypothesis
Does the new 29G/5-bevel needle reduce pain and improve patient satisfaction compared to the 27G/3-bevel needle?
Conclusion
The 29G/5-bevel needle is less painful and easier to use than the 27G/3-bevel needle, leading to higher patient satisfaction.
Supporting Evidence
- 63% of patients reported less pain with the new needle.
- Mean VAS pain scores decreased by 40% with the new needle.
- Patients reported easier skin penetration with the new needle.
Takeaway
A new thinner needle for injections hurts less and is easier to use, making it better for people with multiple sclerosis.
Methodology
Two clinical trials and five surveys were conducted to compare the new needle with the previous design in terms of pain and patient satisfaction.
Potential Biases
The surveys relied on subjective responses, which may introduce bias.
Limitations
The surveys were unblinded and varied in size and question wording.
Participant Demographics
Healthy volunteers and patients with multiple sclerosis from multiple countries.
Statistical Information
P-Value
p < 0.01
Confidence Interval
95% CI: 11.1, 14.6
Statistical Significance
p < 0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website